Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Shop Now at Beast Life
The Future of Retatrutide Retatrutide is part of a new generation of metabolic drugs created to treat obesity and diabetes by targeting several hormonal pathways at the same time
With a growing number of patients using these medications for diabetes or to meet certain optimization goals before undergoing hip and knee reconstructive surgery, our aim was to establish evidence-based guidelines on when to discontinue these to enhance patient safety and surgical success. The study, Optimal Timing for Cessation of GLP-1 Agonist Before Elective Total Hip and Knee Arthroplasty, obtained data from the TriNetX Research Network, a multi-institutional national aggregated database, to identify patients who underwent TKA or THA from January 1, 2018 to January 1, 2023
Tratamiento general 74, 75
DOSE: An R/Bioconductor package for disease ontology semantic and enrichment analysis
US$ 20.96
US$ 22.99
US$ 27.99
